Decreased Visfatin after Exercise Training Correlates with Improved Glucose Tolerance

Medicine and Science in Sports and Exercise

Volumn 41, Issue 6, 2009, Pages 1255-1260

  Haus, Jacob M ^a,b   Solomon, Thomas P J ^a   Marchetti, Christine M ^c   O'leary, Valerie B ^a   Brooks, Latina M ^a   Gonzalez, Frank ^d   Kirwan, John P ^a,b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CLEVELAND STATE UNIVERSITY   (United States)

^d MAYO CLINIC   (United States)

Author keywords

Adipokine; Insulin resistance; Oral glucose tolerance test; Visceral fat

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; GLUCOSE; INSULIN; LEPTIN; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; TUMOR NECROSIS FACTOR ALPHA; GLUCOSE BLOOD LEVEL;

ADULT; ARTICLE; BIOSYNTHESIS; BODY COMPOSITION; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; EXERCISE; EXERCISE INTENSITY; FEMALE; GLUCOSE TOLERANCE; HUMAN; INSULIN RESISTANCE; INTRAABDOMINAL FAT; MALE; OBESITY; ORAL GLUCOSE TOLERANCE TEST; OUTCOME ASSESSMENT; OXYGEN CONSUMPTION; PANCREAS ISLET BETA CELL; TRAINING; WEIGHT REDUCTION; AGED; BLOOD; COMPARATIVE STUDY; FITNESS; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; MOTOR ACTIVITY; PATHOPHYSIOLOGY; STATISTICS;

ADIPOKINES; AGED; BLOOD GLUCOSE; EXERCISE; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; MALE; MOTOR ACTIVITY; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OBESITY; PHYSICAL FITNESS; STATISTICS AS TOPIC;

EID: 67650081527     PISSN: 01959131     EISSN: 15300315     Source Type: Journal    
DOI: 10.1249/MSS.0b013e318195bad5     Document Type: Article

References (38)

1. Abrams HL. McNeil BJ. Medical implications of computed topography (''CAT scanning''). N Engl J Med.1978;298:255-61.
2. Arner P. Insulin resistance in type 2 diabetes-role of the adipokines. Curr Mol Med.2005;5:333-9.
3. Berggren JR. Hulver MW. Houmard JA. Fat as an endocrine organ: influence of exercise. J Appl Physiol.2005;99:757-64.
4. Berndt J. Kloting N. Kralisch S. et al. Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. Diabetes.2005;54:2911- 6.
5. Bourey RE. Kohrt WM. Kirwan JP. Staten MA. King DS. Holloszy JO. Relationship between glucose tolerance and glucose-stimulated insulin response in 65-year-olds. JGerontol.1993;48:M122-7.
6. Brema I. Hatunic M. Finucane F. et al. Plasma visfatin is reduced after aerobic exercise in early onset type 2 diabetes mellitus. Diabetes Obes Metab.2008;10:600-2.
7. Chen CC. Li TC. Li CI. et al. The relationship between visfatin levels and anthropometric and metabolic parameters: association with cholesterol levels in women. MetabClinExp.2007;56: 1216-20.
8. Chen MP. Chung FM. Chang DM. et al. Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab.2006;91:295-9.
9. Choi KM. Kim JH. Cho GJ. Baik SH. Park HS. Kim SM. Effect of exercise training on plasma visfatin and eotaxin levels. Eur J Endocrinol. 2007;157:437-42.
10. Curat CA. Wegner V. Sengenes C. et al. Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin. Diabetologia.2006;49:744-7.
11. del Aguila LF. Claffey KP. Kirwan JP. TNF-a impairs insulin signaling and insulin stimulation of glucose uptake in C2C12 muscle cells. Am J Physiol.1999;276:E849-55.
12. Evans EM. Van Pelt RE. Binder EF. Williams DB. Ehsani AA. Kohrt WM. Effects of HRT and exercise training on insulin action. glucose tolerance. and body composition in older women. J Appl Physiol.2001;90:2033-40.
13. Frydelund-Larsen L. Akerstrom T. Nielsen S. Keller P. Keller C. Pedersen BK. Visfatin mRNA expression in human subcutaneous adipose tissue is regulated by exercise. Am J Physiol.2007;292 :E24-31.
14. Fukuhara A. Matsuda M. Nishizawa M. et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science.2005;307:426- 30.
15. Fukuhara A. Matsuda M. Nishizawa M. et al. Retraction. Science.2007;318:565.
16. Gallagher D. Kuznia P. Heshka S. et al. Adipose tissue in muscle: a novel depot similar in size to visceral adipose tissue. Am J Clin Nutr.2005;81:903-10.
17. Goodpaster BH. Krishnaswami S. Harris TB. et al. Obesity. regional body fat distribution. and the metabolic syndrome in older men and women. Arch Intern Med.2005;165:777-83.
18. Goodpaster BH. Krishnaswami S. Resnick H. et al. Association between regional adipose tissue distribution and both type 2 diabetes and impaired glucose tolerance in elderly men and women. Diabetes Care.2003;26:372-9.
19. Haider DG. Mittermayer F. Schaller G. et al. Free fatty acids normalize a rosiglitazone-induced visfatin release. Am J Physiol.2006;291:E885-90.
20. Haider DG. Pleiner J. Francesconi M. Wiesinger GF. Muller M. Wolzt M. Exercise training lowers plasma visfatin concentrations in patients with type 1 diabetes. J Clin Endocrinol Metab.2006;91:4702-4.
21. Haider DG. Schaller G. Kapiotis S. Maier C. Luger A. Wolzt M. The release of the adipocytokine visfatin is regulated by glucose and insulin. Diabetologia.2006;49:1909-14.
22. Haider DG. Schindler K. Schaller G. Prager G. Wolzt M. Ludvik B. Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding. J Clin Endocrinol Metab.2006;91:1578-81.
23. Hammarstedt A. Pihlajamaki J. Rotter Sopasakis V. et al. Visfatin is an adipokine. but it is not regulated by thiazolidinediones. J Clin Endocrinol Metab.2006;91:1181-4.
24. Hotamisligil GS. Shargill NS. Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science.1993;259:87-91.
25. Hughes VA. Fiatarone MA. Fielding RA. et al. Exercise increases muscle GLUT 4 levels and insulin action in subjects with impaired glucose tolerance. Am J Physiol.1993;264:E855-62.
26. Kadowaki T. Yamauchi T. Kubota N. Hara K. Ueki K. Adiponectin and adiponectin receptors in obesity-linked insulin resistance. Novartis Found Symp.2007;286:164-76; discussion 176-82. 200-3.
27. Kirwan JP. Kohrt WM. Wojta DM. Bourey RE. Holloszy JO. Endurance exercise training reduces glucose-stimulated insulin levels in 60- to 70-year-old men and women. J Gerontol.1993;48:M84-90.
28. Kirwan JP. Krishnan RK. Weaver JA. del Aguila LF. Evans WJ. Human aging is associated with altered TNF-α production during hyperglycemia and hyperinsulinemia. Am J Physiol.2001;281: E1137-43.
29. O'Leary VB. Marchetti CM. Krishnan RK. Stetzer BP. Gonzalez F. Kirwan JP. Exercise-induced reversal of insulin resistance in obese elderly is associated with reduced visceral fat. J Appl Physiol.2006;100:1584-9.
30. Oki K. Yamane K. Kamei N. Nojima H. Kohno N. Circulating visfatin level is correlated with inflammation. but not with insulin resistance. Clin Endocrinol (Oxf).2007;67:796-800.
31. Revollo JR. Korner A. Mills KF. et al. Nampt/PBEF/visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme. Cell Metab.2007;6:363-75.
32. Samal B. Sun Y. Stearns G. Xie C. Suggs S. McNiece I. Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor. Mol Cell Biol.1994;14:1431-7.
33. Scherer PE. Williams S. Fogliano M. Baldini G. Lodish HF. A novel serum protein similar to C1q. produced exclusively in adipocytes. J Biol Chem.1995;270:26746-9.
34. Sethi JK. Is PBEF/visfatin/Nampt an authentic adipokine relevant to the metabolic syndrome? Curr Hypertens Rep.2007;9:33-8.
35. Tanaka M. Nozaki M. Fukuhara A. et al. Visfatin is released from 3T3-L1 adipocytes via a non-classical pathway. Biochem Biophys Res Commun.2007;359:194-201.
36. Varma V. Yao-Borengasser A. Rasouli N. et al. Human visfatin expression: relationship to insulin sensitivity. intramyocellular lipids. and inflammation. J Clin Endocrinol Metab.2007;92:666-72.
37. Vu V. Riddell MC. Sweeney G. Circulating adiponectin and adiponectin receptor expression in skeletal muscle: effects of exercise. Diabetes Metab Res Rev.2007;23:600-11.
38. Wei Y. Chen K. Whaley-Connell AT. Stump CS. Ibdah JA. Sowers JR. Skeletal muscle insulin resistance: role of inflammatory cytokines and reactive oxygen species. Am J Physiol Regul Integr Comp Physiol.2008;294:R673-80.